Apollo Medical Holdings Inc (NASDAQ:AMEH) Insider Sells $1,697,696.00 in Stock

Share on StockTwits

Apollo Medical Holdings Inc (NASDAQ:AMEH) insider Adrian Vazquez sold 84,800 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $20.02, for a total value of $1,697,696.00.

Shares of AMEH traded up $0.36 during mid-day trading on Tuesday, reaching $20.61. The company’s stock had a trading volume of 976 shares, compared to its average volume of 159,887. Apollo Medical Holdings Inc has a 12-month low of $13.36 and a 12-month high of $23.32. The stock has a market cap of $698.97 million, a PE ratio of 69.83, a price-to-earnings-growth ratio of 11.80 and a beta of -0.96. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.14 and a quick ratio of 2.14. The company’s 50 day moving average is $17.35 and its 200 day moving average is $17.72.

Apollo Medical (NASDAQ:AMEH) last released its quarterly earnings data on Friday, August 9th. The company reported $0.09 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.04. Apollo Medical had a return on equity of 5.28% and a net margin of 1.94%. The business had revenue of $130.05 million for the quarter. As a group, sell-side analysts anticipate that Apollo Medical Holdings Inc will post 0.33 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in shares of Apollo Medical by 9.6% in the 2nd quarter. Vanguard Group Inc. now owns 1,164,827 shares of the company’s stock valued at $19,464,000 after acquiring an additional 102,267 shares during the last quarter. BlackRock Inc. increased its holdings in shares of Apollo Medical by 98.7% in the 2nd quarter. BlackRock Inc. now owns 728,124 shares of the company’s stock valued at $12,167,000 after acquiring an additional 361,766 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Apollo Medical by 2.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 61,347 shares of the company’s stock valued at $1,025,000 after acquiring an additional 1,205 shares during the last quarter. Wells Fargo & Company MN increased its holdings in shares of Apollo Medical by 23.4% in the 2nd quarter. Wells Fargo & Company MN now owns 32,722 shares of the company’s stock valued at $547,000 after acquiring an additional 6,215 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Apollo Medical by 52.4% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 19,822 shares of the company’s stock valued at $332,000 after acquiring an additional 6,816 shares during the last quarter. Institutional investors and hedge funds own 7.93% of the company’s stock.

A number of research firms have issued reports on AMEH. TheStreet raised Apollo Medical from a “d” rating to a “c-” rating in a research report on Friday, June 28th. ValuEngine downgraded Apollo Medical from a “buy” rating to a “hold” rating in a report on Tuesday, August 20th. Finally, Zacks Investment Research downgraded Apollo Medical from a “hold” rating to a “strong sell” rating in a report on Friday, August 9th.

About Apollo Medical

Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Featured Article: What is net income?

Insider Buying and Selling by Quarter for Apollo Medical (NASDAQ:AMEH)

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

AstraZeneca  Scheduled to Post Earnings on Thursday
AstraZeneca Scheduled to Post Earnings on Thursday
Allied Properties Real Estate Investment Trust  Set to Announce Quarterly Earnings on Wednesday
Allied Properties Real Estate Investment Trust Set to Announce Quarterly Earnings on Wednesday
Aptinyx Inc  Receives Average Rating of “Buy” from Brokerages
Aptinyx Inc Receives Average Rating of “Buy” from Brokerages
MGIC Investment  Shares Gap Up  Following Earnings Beat
MGIC Investment Shares Gap Up Following Earnings Beat
Zions Bancorporation NA Target of Unusually Large Options Trading
Zions Bancorporation NA Target of Unusually Large Options Trading
Eltek  Upgraded by ValuEngine to “Buy”
Eltek Upgraded by ValuEngine to “Buy”


© 2006-2019 Ticker Report